tiprankstipranks
Trending News
More News >

Eyenovia Announces $50M Private Placement and New CIO

Story Highlights
  • Eyenovia announced a $50 million private placement to build a HYPE token reserve.
  • Eyenovia appointed Hyunsu Jung as Chief Investment Officer and will continue developing its Optejet device.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Eyenovia Announces $50M Private Placement and New CIO

Confident Investing Starts Here:

The latest update is out from Eyenovia ( (EYEN) ).

On June 17, 2025, Eyenovia, Inc. announced a $50 million private placement with institutional investors to build a reserve of the HYPE token, part of its new cryptocurrency treasury strategy. The company also appointed Hyunsu Jung as Chief Investment Officer and Board Member. This move positions Eyenovia as a pioneer in integrating cryptocurrency into its treasury, potentially enhancing its market positioning and offering long-term value to shareholders. Concurrently, Eyenovia will continue focusing on its existing business, including the development of the Gen-2 Optejet User Filled Device, with plans to register it with the FDA by September 2025.

The most recent analyst rating on (EYEN) stock is a Buy with a $560.00 price target. To see the full list of analyst forecasts on Eyenovia stock, see the EYEN Stock Forecast page.

Spark’s Take on EYEN Stock

According to Spark, TipRanks’ AI Analyst, EYEN is a Underperform.

Eyenovia’s stock is heavily weighed down by poor financial performance, including significant operational losses and a weak balance sheet. While there is revenue growth, the negative equity and insufficient cash flow generation are critical risks. Technical indicators also point to a bearish trend, and the valuation metrics are unappealing due to a negative P/E ratio and absence of dividends. These factors result in a low overall score.

To see Spark’s full report on EYEN stock, click here.

More about Eyenovia

Eyenovia, Inc. is a digital ophthalmic technology company that is pioneering the integration of blockchain technology into its operations. The company is developing the Optejet User Filled Device for topical ophthalmic treatments and is the first U.S. publicly listed company to build a strategic treasury of Hyperliquid’s native token, HYPE, aiming to provide shareholders with access to the growing blockchain ecosystem.

Average Trading Volume: 3,334,757

Technical Sentiment Signal: Sell

Current Market Cap: $12.14M

For an in-depth examination of EYEN stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1